The effect of hormone replacement therapy on the sensitivity of screening mammograms

Clinical Radiology

Volumn 54, Issue 5, 1999, Pages 285-288

  Litherland, J C ^a   Stallard, S ^a   Hole, D ^b   Cordiner, C ^a  

^a West of Scotland Breast Screening Service   (United Kingdom)

^b W of Scotland Cancer Survlnc Unit   (United Kingdom)

Author keywords

Breast cancers; Hormone replacement therapy (HRT); Interval; Mammographic sensitivity; Screen detected

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER SCREENING; DENSITY; DIAGNOSTIC ACCURACY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032935148     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9260(99)90555-X     Document Type: Article

References (19)

1. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108411 women without breast cancer. Lancet 1997; 350: 1047-1059.
2. van Gils CH, Otten JDM, Verbeek ALM et al. Short communication: breast parenchymal patterns and their changes with age. Br J Radiol 1995; 68: 1133-1135.
3. Kaufman Z, Garstin WIH, Hayes R et al. The mammographic parenchymal patterns of women on hormone replacement therapy. Clin Radiol 1991; 43: 389-392.
4. Berkowitz JE, Gatewood OMB, Goldblum LE et al Hormone replacement therapy: mammographie manifestations. Radiology 1990; 174: 199-201.
5. Stamper PC, Van Voohis BJ, Ravnikar VA et al. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology 1990; 174: 487-490.
6. Cyrlak D, Wong CH. Mammographic changes in postmenopausal women undergoing hormone replacement therapy. Am J Roentgenol 1993; 161: 1177-1183.
7. Carstairs V, Morris R. Deprivation and health in Scotland. Aberdeen: Aberdeen University Press, 1991.
8. Scottish Health Statistics Table 7.6. Source: Department of Health and Social Security: Information & Statistics Division: Edinburgh 1986-1995.
9. Peck DR, Lowman RM. Estrogen and the postmenopausal breast. JAMA 1978; 240: 1733-1735.
10. Meyer JE, Frcnna TH, Polger M et al. Enlarging occult fibroadenomas. Radiology 1992; 183: 639-641.
11. Doyle GJ, Mclean L. Unilateral increase in mammographic density with hormone replacement therapy. Clin Radiol 1994; 49: 50-51.
12. Laya MB, Gallagher JC, Schreiman JS et al. Effect of postmenopausal hormonal replacement therapy on mammographie density and parenchymal pattern. Radiology 1995; 196: 433-437.
13. McNicholas MMJ, Heneghan JP, Milner MH et al Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study. Am J Roentgenol 1994; 163: 311-315.
14. Stomper PC, D'Souza DJ, DiNitto PA et al. Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. Am J Roentgenol 1996; 167: 1261-1265.
15. Laya M, Larson EB, Taplin SH et al. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 1996; 88: 643-649.
16. Litherland JC, Evans AJ, Wilson ARM. The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme. Clin Radiol 1997; 52: 276-279.
17. Cohen MEL. Effect of hormone replacement therapy on cancer detection by mammography. Lancet 1997; 349: 1624.
18. Roubidoux MA, Wilson TE, Orange RJ et al. Breast cancer in women who undergo screening mammography: relationship of hormone replacement therapy to stage and detection method. Radiology 1998; 208: 725-728.
19. Threlfall AG, Woodman CNJ, Prior P. Breast screening programme: should the interval between tests depend on age? Lancet 1997; 349:472.